Industry estimates put a four-week supply near 150,000 won, below Mounjaro's 272,000 won, with launch possible before year-end pending approval.
Recap by typeshit. Full story at The Korea Herald.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Prosecutors say the fake pens came from China and hit over 150 pharmacies and businesses. One defendant was extradited from Italy, and each faces up to 71 years if convicted.
Presented at EASD, the analysis put Foundayo 17.2 mg ahead by 1.5% in weight loss and 0.3% in A1C at 52 weeks, though no head-to-head trial was run.
Loading…